FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to medicine, namely to therapeutic agents used for treating ischemic cardiac disorders, and describes a combined medicine as a thrombocyte aggregation inhibitor containing an agent presented by a combination of clopidogrel or a pharmaceutically acceptable salt thereof, acetyl salicylic acid and magnesium hydroxide and additives.
EFFECT: invention provides enlarging the list of medicines and preparing the new combination of the agents possessing activity on platelet aggregation and the property to protect the gastric mucosa, as well as enhancing the clinical effectiveness of the medicine and prolonging its action.
13 cl, 3 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SOLID DOSAGE FORM OF CLOPIDOGREL AND METHOD FOR PREPARING THEREOF | 2009 |
|
RU2393862C1 |
| PHARMACEUTICAL AGENT WITH CARDIOVASCULAR EFFECT | 2001 |
|
RU2206316C1 |
| PELLETISED CLOPIDOGREL OR ITS PHARMACEUTICALLY ACCEPTABLE SALT FORMULATION, METHOD OF OBTAINMENT AND APPLICATION | 2007 |
|
RU2349304C1 |
| THROMBOSIS INHIBITOR PREPARATIONS | 2010 |
|
RU2538616C2 |
| THIENOPYRIDINE ESTER DERIVATIVE, CONTAINING CYANOGROUP, METHOD OF ITS OBTAINING, ITS APPLICATION AND BASED ON IT COMPOSITION | 2011 |
|
RU2526624C2 |
| PHARMACEUTICAL COMPOSITION OF ANTITHROMBOTIC ACTION IN SOLID DOSAGE FORM IN THE FORM OF TABLETS | 2019 |
|
RU2696869C1 |
| PHARMACEUTICAL COMBINATION POSSESSING ANTIAGGREGANT AND LIPID-REGULATING ACTIVITIES, PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2461379C2 |
| COMBINED DRUG PREPARATION CARDIFOL EXHIBITING CARDIOPROTECTIVE, ANTIAGGREGANT AND ANTI-ISCHEMIC ACTION ON CARDIOVASCULAR SYSTEM | 2011 |
|
RU2446806C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING HMG-CoA REDUCTASE INHIBITOR AND ACE INHIBITOR | 2016 |
|
RU2750934C2 |
| ANTITHROMBOTIC COMPOUND | 2012 |
|
RU2604733C2 |
